M-14017 Squamous Cell Carcinoma Antigen (SCCA) Quantitative Test Kit

Clinical Significance: Squamous Cell Carcinoma Antigen (SCCA) is a tumor marker used primarily for the diagnosis and monitoring of squamous cell carcinomas. Elevated levels of SCCA can indicate the presence of squamous cell carcinomas in various organs, including the cervix, lungs, esophagus, head and neck, and skin. Monitoring SCCA levels is useful for assessing treatment response, detecting recurrence, and evaluating disease progression.
Product Specifications: 20 tests per box
Product Shelf Life: Sealed in an aluminum foil bag, the product is valid for 18 months. Once opened, the aluminum foil bag should be used within 1 hour.
Product Storage: Store the test cards at 2°C to 30°C.
 
Usage Scenarios:
Hospitals and Oncology Departments: For diagnosing and monitoring squamous cell carcinomas in various organs, including the cervix, lungs, esophagus, head and neck, and skin, by tracking SCCA levels.
Diagnostic Laboratories: For routine testing of serum SCCA levels to aid in the diagnosis, treatment assessment, and monitoring of squamous cell carcinomas.
Cancer Screening Programs: For regular screening and monitoring of high-risk populations for early detection and management of squamous cell carcinomas.
Dermatology Clinics: For diagnosing and monitoring skin squamous cell carcinomas.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are widely used for comprehensive cancer management and early detection.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving diagnostic capabilities for cancer and expanding access to modern diagnostic tools.
Global Health Programs: International health initiatives focused on enhancing cancer detection and management in low-resource settings.